COVID-19 Related Immunisation Disruptions from 2020-2030: Projecting Health Impact and Mitigation Strategies for 14 Pathogens Across 112 Low- and Middle-Income Countries
Hartner A, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers M, Ferrari M, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Prasinou A, Moore S, Nayagam S, Papadopoulos T, Perkins T, Portnoy A, Tran Q, Vynnycky E, Winter A, Burrows H, Chen C, Clapham H, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim J, Koh J, Lopman B, Pitzer V, Tam Y, Lambach P, Sim S, Woodruff K, Ferguson N, Trotter C, Gaythorpe K. COVID-19 Related Immunisation Disruptions from 2020-2030: Projecting Health Impact and Mitigation Strategies for 14 Pathogens Across 112 Low- and Middle-Income Countries. 2023 DOI: 10.2139/ssrn.4492698.Peer-Reviewed Original ResearchMedical Research CouncilHuman papillomavirusVaccine preventable disease burdenYellow fever vaccinationUK Medical Research CouncilSubsets of diseaseEDCTP2 programmeImmunisation effortsHPV vaccineFever vaccinationMiddle-income countriesImmunisation coverageVaccine coverageVaccination coverageLong-term impactDisease burdenVaccination activitiesPersonal feesSanofi PasteurAdditional deathsSpeaker feesExcess deathsMRC CentreMeningitis AEpidemiologic research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply